The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,184.00
Bid: 12,182.00
Ask: 12,186.00
Change: -62.00 (-0.51%)
Spread: 4.00 (0.033%)
Open: 12,240.00
High: 12,306.00
Low: 12,132.00
Prev. Close: 12,246.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK BROKER RATINGS SUMMARY: Peel Hunt Cuts Grafton After Warning

Thu, 17th Oct 2019 09:30

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning:

----------

FTSE 100

----------

GOLDMAN CUTS ROLLS-ROYCE PRICE TARGET TO 1196 (1232) PENCE - 'CONVICTION BUY'

----------

INVESTEC RAISES AVIVA TO 'BUY' ('ADD') - TARGET 455 (385) PENCE

----------

BARCLAYS RAISES ST JAMES'S PLACE PRICE TARGET TO 1241 (1155) P - 'OVERWEIGHT'

----------

CS RAISES NATIONAL GRID TO 'OUTPERFORM' (NEUTRAL) - PRICE TARGET 970 (810) PENCE

----------

HSBC RAISES ASTRAZENECA PRICE TARGET TO 6235 (5180) PENCE - 'REDUCE'

----------

JEFFERIES CUTS ROYAL DUTCH SHELL PRICE TARGET TO 2780 (2900) PENCE - 'BUY'

----------

JEFFERIES CUTS BP PRICE TARGET TO 590 (625) PENCE - 'BUY'

----------

GOLDMAN CUTS ANGLO AMERICAN TARGET TO 2300 (2450) PENCE - 'CONVICTION BUY LIST'

----------

GOLDMAN CUTS GLENCORE PRICE TARGET TO 210 (220) PENCE - 'NEUTRAL'

----------

GOLDMAN CUTS RIO TINTO PRICE TARGET TO 5100 (5250) PENCE - 'BUY'

----------

GOLDMAN CUTS BHP GROUP PRICE TARGET TO 1900 (2100) PENCE - 'NEUTRAL'

----------

GOLDMAN RAISES ANTOFAGASTA PRICE TARGET TO 950 (850) PENCE - 'NEUTRAL'

----------

JPMORGAN CUTS ANTOFAGASTA PRICE TARGET TO 750 (810) PENCE - 'UNDERWEIGHT'

----------

JPMORGAN CUTS BURBERRY GROUP PRICE TARGET TO 1950 (2000) PENCE - 'NEUTRAL'

----------

FTSE 250

----------

PEEL HUNT CUTS GRAFTON GROUP TO 'HOLD' ('ADD') - TARGET 800 (860) PENCE

----------

JEFFERIES CUTS BELLWAY TO 'HOLD' ('BUY') - TARGET 3743 (3875) PENCE

----------

UBS CUTS WEIR GROUP TO 'NEUTRAL' ('BUY') - TARGET 1450 (1550) PENCE

----------

HSBC CUTS WEIR GROUP PRICE TARGET TO 1820 (1870) PENCE - 'BUY'

----------

RBC CUTS RATHBONE BROTHERS PRICE TARGET TO 2450 (2500) PENCE - 'SECTOR PERFORM'

----------

RBC RAISES LANCASHIRE HOLDINGS PRICE TARGET TO 775 (750) PENCE - 'OUTPERFORM'

----------

BERENBERG CUTS CENTAMIN PRICE TARGET TO 113 (120) PENCE - 'HOLD'

----------

HSBC RAISES WIZZ AIR PRICE TARGET TO 3250 (3100) PENCE - 'HOLD'

----------

HSBC RAISES EASYJET PRICE TARGET TO 1450 (1300) PENCE - 'BUY'

----------

BERENBERG RAISES IBSTOCK PRICE TARGET TO 310 (300) PENCE - 'BUY'

----------

GOLDMAN CUTS KAZ MINERALS TO 'NEUTRAL' ('BUY') - TARGET 475 (675) PENCE

----------

OTHER MAIN MARKET AND AIM

----------

BERENBERG RAISES ASOS PRICE TARGET TO 3000 (2500) PENCE - 'HOLD'

----------

BERENBERG RAISES FORTERRA PRICE TARGET TO 310 (290) PENCE - 'HOLD'

----------

Copyright 2019 Alliance News Limited. All Rights Reserved.

More News
1 Dec 2023 08:52

LONDON MARKET OPEN: Miners give FTSE 100 boost thanks to China PMI

(Alliance News) - Stock prices in London opened higher on Friday, with the FTSE 100 boosted by mining stocks.

Read more
1 Dec 2023 08:33

AstraZeneca discontinues two phase III evidence trials for Lokelma

(Alliance News) - AstraZeneca on Friday said it has decided to discontinue the Stabilize-CKD and Dialize-outcomes phase III trials for Lokelma, citing increased enrolment timelines.

Read more
1 Dec 2023 08:01

AstraZeneca calls off two phase III trials into hyperkalaemia treatment

(Sharecast News) - Drugmaker AstraZeneca has called off two phase III trials on its hyperkalaemia treatment after a series of logistical challenges.

Read more
1 Dec 2023 07:41

LONDON BRIEFING: Stocks called higher; UK house prices fall annually

(Alliance News) - Stocks in London are called to open higher on Friday, following data from Nationwide showing that the annual pace of UK house price decline slowed in November.

Read more
27 Nov 2023 16:12

London close: Stocks start week in subdued state

(Sharecast News) - London's financial markets saw a somewhat subdued performance on Monday, as concerns regarding the Chinese economy cast a shadow over investor sentiment.

Read more
27 Nov 2023 09:20

LONDON BROKER RATINGS: Peel, Numis up Rightmove; Goldman cuts Entain

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
23 Nov 2023 18:41

IN BRIEF: AstraZeneca Chair Demare buys shares for over GBP200,000

AstraZeneca PLC - Cambridge-based pharmaceutical company - Chair Michel Demare buys 2,000 shares in total on Wednesday and Tuesday. Buys 1,000 shares for GBP101.05 each on Tuesday and 1,000 shares for GBP101.70 each on Thursday, for a total of GBP202,752.

Read more
20 Nov 2023 10:49

AstraZeneca launches new life sciences tech innovation firm Evinova

(Alliance News) - AstraZeneca PLC on Monday launched Evinova, a new health technology business focused on accelerating innovation across the life sciences sector, delivery of clinical trials and better health outcomes.

Read more
17 Nov 2023 15:20

London close: Stocks higher despite weaker retail sales data

(Sharecast News) - London's stock markets finished in a positive state on Friday despite weaker-than-expected UK retail sales figures.

Read more
17 Nov 2023 12:00

LONDON MARKET MIDDAY: Stocks shrug off downbeat UK retail sales

(Alliance News) - Stock prices in London were up at midday on Friday, as a week of favourable data as far as inflation goes gave investors a reason to overlook disappointing UK retail sales figures.

Read more
17 Nov 2023 09:03

LONDON MARKET OPEN: Stocks up despite UK retail sales growth miss

(Alliance News) - Stock prices in London opened higher on Friday, despite weaker-than-expected October retail sales figures for the UK.

Read more
17 Nov 2023 08:31

TOP NEWS: US approves AstraZeneca's Truqap for form of breast cancer

(Alliance News) - AstraZeneca PLC on Friday said that the US Food & Drug Administration approved its drug Truqap in combination with Faslodex to treat patients with an advanced form of breast cancer.

Read more
17 Nov 2023 07:58

LONDON BRIEFING: UK retail sales fall; AstraZeneca gets US approval

(Alliance News) - Stock prices in London are still set to open higher on Friday, despite October retail sales figures for the UK disappointing shortly before the opening bell.

Read more
17 Nov 2023 07:16

AstraZeneca gets US approval for breast cancer treatment

(Sharecast News) - AstraZeneca's 'Truqap', or capivasertib, in combination with 'Faslodex', or fulvestrant, has secured approval from the US Food and Drug Administration (FDA) for specific breast cancer treatments, the company announced on Friday.

Read more
14 Nov 2023 10:51

TOP NEWS: AstraZeneca Imfinzi fails to meet endpoint in cancer trial

(Alliance News) - AstraZeneca PLC on Tuesday said the Pacific-2 phase III trial for Imfinzi as an early treatment lung cancer immunotherapy treatment administered with chemoradiotherapy, did not meet its primary endpoint.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.